HALOZYME THERAPEUTICS, INC.: operating_income
| Value | {"amount": -80434000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/929def42-f84c-4456-8386-e61cd2f1f4ce
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-15-000041Retrieved: 2026-08-19T11:36:26.700322+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/operating-income/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/929def42-f84c-4456-8386-e61cd2f1f4ce
History
- supersedes {"amount": -80433637, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001159036-14-000033)